Norwood Medical, a provider of advanced, outsourced medical manufacturing services, has appointed Jim Kircher as its new CEO.
 
Kircher succeeds Dr. Frank Stietz, member of Heraeus Group’s board of managing directors. Heraeus acquired Norwood Medical in December 2021. Dr. Stietz led Norwood for the past two years to facilitate its integration in the Heraeus Group. He has returned to Germany to continue his role on Heraeus’ board and serve as the company’s chief operating officer.
 
Kircher has extensive experience in international operations, micro-manufacturing, engineering, commercial strategy, and leading companies into growth and expansion. He was most recently CEO of Libra Industries, a manufacturing and systems integrator. Before that, he had senior leadership roles at Jabil, Flextronics, Boeing, and McDonnel Douglas.
 
Last March, Norwood broke ground for the construction of its eleventh building, a 72,000-square-foot manufacturing facility. It will focus on producing components for minimally invasive, robotic-assisted surgeries as well as orthopedics.
 
When the building is operational in Q2 2024, it will enable the company to continue increasing its capabilities in electro-chemical machining, laser-induced processes, automation, and metal injection molding (MIM). The company aims to produce 35 million parts per year.
 
Kircher said, “It is an honor to lead Norwood because it has earned such an unmatched reputation for excellence and innovation with its medical device customers. Another thing that has truly impressed me has been every employee’s sacred commitment to put the patient at the center of everything they do. That mission and mindset will enable us to continue to deliver new medical technology breakthroughs that improve patient care and treatment outcomes.”